Curcumin and indole pharmaceutical co-crystal with high safety and anticancer activity and preparation method of curcumin and indole pharmaceutical co-crystal
An anti-cancer activity, indole co-crystal technology, applied in anti-tumor drugs, drug combinations, organic chemical methods, etc., can solve the problems of thermodynamic instability, prone to agglomeration, poor stability, etc., achieve good hygroscopicity, avoid crystal formation. The effect of transformation and environmental pollution is small
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Preparation of curcumin-indole drug co-crystal: accurately weigh 100 mg of curcumin and 31.8 mg of indole with a molar ratio of 1:1 with an electronic balance, mix well with a vortex mixer, add 30 mL of acetone, and ultrasonically dissolve the drug completely And mix evenly, transfer to a round bottom flask, use a vacuum rotary evaporation evaporator at a water bath temperature of 40 ° C, a rotation speed of 200 r / min, rotary evaporation under vacuum conditions to completely remove the solvent, and then place it in a 40 ° C vacuum oven for drying Overnight, the solvent was completely evaporated to obtain an orange-red solid powder product.
[0050] The curcumin that embodiment 1 obtains and the indole cocrystal carry out X-ray powder diffraction (PXRD) characterization, and instrument is German Bruker D8 Advance, and the PXRD collection of illustrative plates that obtains is as attached figure 1 Shown in, wherein a is the PXRD collection of illustrative plates of curcum...
Embodiment 2
[0063] Preparation of curcumin-indole drug co-crystal: accurately weigh 100 mg of curcumin and 63.6 mg of indole with a molar ratio of 1:2 with an electronic balance, mix well with a vortex mixer, add 30 mL of acetone, and ultrasonically dissolve the drug completely And mix evenly, transfer to a round bottom flask, use a vacuum rotary evaporation evaporator at a water bath temperature of 40 ° C, a rotation speed of 200 r / min, rotary evaporation under vacuum conditions to completely remove the solvent, and then place it in a 40 ° C vacuum oven for drying Overnight, the solvent was completely evaporated to obtain an orange-red solid powder product.
[0064] figure 1 The PXRD spectrum shown, image 3 The characteristics of the DSC spectrum shown and Figure 4 Shown infrared spectrogram feature, illustrates that the solid product gained in the present embodiment is curcumin and indole eutectic.
[0065] Carry out solubility test to embodiment 2, the result is similar to embodim...
Embodiment 3
[0070] Preparation of curcumin-indole drug co-crystal: accurately weigh 100 mg of curcumin and 95.4 mg of indole with a molar ratio of 1:3 with an electronic balance, mix well with a vortex mixer, add 30 mL of acetone, and ultrasonically dissolve the drug completely And mix evenly, transfer to a round bottom flask, use a vacuum rotary evaporation evaporator at a water bath temperature of 40 ° C, a rotation speed of 200 r / min, rotary evaporation under vacuum conditions to completely remove the solvent, and then place it in a 40 ° C vacuum oven for drying Overnight, the solvent is completely volatilized to obtain a solid powder product, which is the co-crystal of curcumin and indole medicine.
[0071] figure 1 The PXRD spectrum shown, image 3 The DSC spectrum shown, Figure 4 The infrared spectrum features shown all illustrate that the solid product obtained in the present embodiment is a cocrystal of curcumin and indole medicine.
[0072] Carry out solubility test to embodi...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


